Status:

COMPLETED

Observational Study of Expected ARF Recovery

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Acute Respiratory Failure

Post Intensive Care Syndrome

Eligibility:

All Genders

18+ years

Brief Summary

This is an observational cohort study of the association between patient expectations for functional recovery and quality of life among acute respiratory failure survivors 6 months after hospital disc...

Detailed Description

This study will enroll adults who are diagnosed with acute respiratory failure during an ICU admission and discharged from the ICU alive. All participants will receive usual clinical care. Participant...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Respiratory failure managed in the ICU, where respiratory failure is defined as ≥1 of the following:
  • Mechanical ventilation via an endotracheal tube ≥ 24 hours OR
  • Non-invasive ventilation (CPAP, BiPAP) ≥ 24 consecutive hours\* provided for acute respiratory failure (not for Obstructive Sleep Apnea or other stable use) OR
  • High flow nasal cannula with FIO2 ≥ 0.5 and flow rate ≥ 30 LPM for ≥ 24 consecutive hours\*
  • \*Occasional rest periods of ≤ 1 hour each are not deducted from the calculation of consecutive hours.
  • Expected by the clinical team to be discharged home alive

Exclusion

  • Patient in ICU \< 24 hours
  • Mechanical ventilation at baseline or mechanical ventilation solely for airway protection or obstruction
  • Residing in a medical institution at the time of hospital admission
  • Homeless / Prisoner / Primary residence not in the USA / Unable to communicate by telephone in English
  • More than mild dementia (either known diagnosis of moderate or worse dementia or IQ-CODE \> 3.6; screening performed on patients \> 50 years old or with family reports of possible memory decline)
  • Patient on hospice at or before time of enrollment
  • Patients who, based solely on pre-existing medical problems (such as poorly controlled neoplasm or other end stage disease, including Stage IV heart failure or severe burns), would not be expected to survive 6 months in the absence of the acute respiratory failure.
  • Patients with neurological injury either receiving treatment for intracranial hypertension or who are not expected to return to consciousness.
  • Pregnancy

Key Trial Info

Start Date :

January 22 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2021

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT03797313

Start Date

January 22 2019

End Date

December 1 2021

Last Update

December 15 2021

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Johns Hopkins University

Baltimore, Maryland, United States, 21287

2

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

3

Vanderbilt University

Nashville, Tennessee, United States, 37235

4

Intermountain Medical Center

Murray, Utah, United States, 84107